Search results
1 lip 2022 · The aim of this mini- review was to collect and analyze published data on this topic in a trial to answer some questions related to the benefits versus the risks of offering frequent boosters of mRNA vaccines for increasing the population immunity against COVID-19 infection considering the current policy of providing SARS-CoV-2 vaccine booster ...
2 lis 2021 · The authors provide an overview of current literature available to assess the need for COVID-19 vaccine booster doses and their potential target population.
2 lip 2022 · The number of COVID-19 vaccine-rich countries that have started COVID-19 third-dose booster programs is growing dramatically despite the lack of robust evidence on the effectiveness, safety, and frequency of the required booster doses that makes the individuals/populations immune to COVID -19 infect ….
30 lis 2021 · The recommended dose for the Pfizer/BioNTech booster and Johnson and Johnson booster is the same as the initial dose. For the Moderna booster it's a half-dose, which may reduce the risk of side effects and increase the number of doses available to others.
22 gru 2021 · Optimal timing of booster doses, possibility for dose-sparing for booster doses (e.g. fractional doses), booster needs in previously infected individuals, programmatic feasibility and sustainability, community perception and demand as well as equity considerations.
27 paź 2023 · CC+mRNA, CCC, and CCA denote individuals with a primary series of CoronaVac plus a first mRNA, homologous, and a ChAdOx-1 first booster dose, respectively.
9 paź 2021 · Why a booster dose? The most effective regimen for Coronavirus Infectious Disease 19 (COVID-19) vaccination is still unknown as data keep evolving following the waning of immunity over time and the occurrence of new variants.
